CDNA vs. NVDA
CDNA (CareDx, Inc) and NVDA (NVIDIA Corporation) are both stocks. CDNA operates in Diagnostics & Research (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 10 years, CDNA returned 18.09%/yr vs 68.65%/yr for NVDA. At a 0.25 correlation, their price movements are largely independent.
Performance
CDNA vs. NVDA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDNA achieves a 32.96% return, which is significantly higher than NVDA's 12.01% return. Over the past 10 years, CDNA has underperformed NVDA with an annualized return of 18.09%, while NVDA has yielded a comparatively higher 68.65% annualized return.
CDNA
- 1D
- -4.32%
- 1M
- 15.81%
- YTD
- 32.96%
- 6M
- 25.12%
- 1Y
- 31.57%
- 3Y*
- 47.04%
- 5Y*
- -23.19%
- 10Y*
- 18.09%
NVDA
- 1D
- -0.97%
- 1M
- -2.99%
- YTD
- 12.01%
- 6M
- 13.73%
- 1Y
- 45.24%
- 3Y*
- 70.46%
- 5Y*
- 61.50%
- 10Y*
- 68.65%
CDNA vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CDNA CareDx, Inc | 32.96% | -12.00% | 78.42% | 5.17% | -74.91% | -37.23% | 235.88% | -14.20% | 242.51% | 171.85% |
NVDA NVIDIA Corporation | 12.01% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
Correlation
The correlation between CDNA and NVDA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jul 17, 2014 | 0.25 |
The correlation between CDNA and NVDA shifts across timeframes, from 0.17 (1 year) to 0.32 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CDNA:
$1.33B
NVDA:
$5.09T
CDNA:
-$0.15
NVDA:
$6.53
CDNA:
3.22
NVDA:
20.13
CDNA:
4.24
NVDA:
26.04
CDNA:
$412.82M
NVDA:
$253.49B
CDNA:
$198.97M
NVDA:
$187.95B
CDNA:
$4.15M
NVDA:
$192.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDNA vs. NVDA — Risk / Return Rank
CDNA
NVDA
CDNA vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CareDx, Inc (CDNA) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDNA | NVDA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.85 | ||
| Sortino ratioReturn per unit of downside risk | -0.77 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.22 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 0.72 | 2.25 | -1.53 |
| Martin ratioReturn relative to average drawdown | 1.50 | 5.27 | -3.77 |
Loading charts...
Drawdowns
CDNA vs. NVDA - Drawdown Comparison
The maximum CDNA drawdown since its inception was -94.87%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for CDNA and NVDA.
Loading charts...
Drawdown Indicators
| CDNA | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.87% | -89.72% | -5.15% |
Max Drawdown (1Y)Largest decline over 1 year | -43.92% | -20.21% | -23.71% |
Max Drawdown (3Y)Largest decline over 3 years | -65.96% | -36.88% | -29.08% |
Max Drawdown (5Y)Largest decline over 5 years | -94.85% | -66.34% | -28.51% |
Max Drawdown (10Y)Largest decline over 10 years | -94.87% | -66.34% | -28.53% |
Current DrawdownCurrent decline from peak | -73.80% | -11.39% | -62.41% |
Average DrawdownAverage peak-to-trough decline | -53.75% | -36.16% | -17.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.10% | 8.61% | +12.49% |
Volatility
CDNA vs. NVDA - Volatility Comparison
CareDx, Inc (CDNA) has a higher volatility of 16.23% compared to NVIDIA Corporation (NVDA) at 12.78%. This indicates that CDNA's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDNA | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.23% | 12.78% | +3.45% |
Volatility (6M)Calculated over the trailing 6-month period | 45.88% | 26.61% | +19.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.34% | 35.31% | +37.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.50% | 51.80% | +25.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.19% | 49.89% | +28.30% |
Dividends
CDNA vs. NVDA - Dividend Comparison
CDNA has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CDNA CareDx, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.13% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
CDNA vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between CareDx, Inc and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CDNA vs. NVDA - Profitability Comparison
CDNA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CareDx, Inc reported a gross profit of 0.00 and revenue of 117.70M. Therefore, the gross margin over that period was 0.0%.
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.
CDNA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CareDx, Inc reported an operating income of 1.20M and revenue of 117.70M, resulting in an operating margin of 1.0%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.
CDNA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CareDx, Inc reported a net income of 2.81M and revenue of 117.70M, resulting in a net margin of 2.4%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.
Frequently Asked Questions
CDNA and NVDA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDNA has higher volatility (16.23%) compared to NVDA (12.78%). In terms of maximum drawdown, CDNA dropped -94.87% vs NVDA's -89.72%.
NVDA currently has the higher Sharpe Ratio (1.29 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDNA and NVDA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer